Lilly CEO Talks Fighting Cancer and Obesity, Drug Pricing
Bloomberg Talks13 Jan 2025

Lilly CEO Talks Fighting Cancer and Obesity, Drug Pricing

Eli Lilly Chief Executive Officer Dave Ricks talks about paying $2.5 billion for a cancer drug being developed by Scorpion Therapeutics. He also says Lilly's experimental weight-loss pill could be approved in early 2026. He speaks to Bloomberg's Katie Greifeld from the JPMorgan Healthcare Conference in San Francisco.

See omnystudio.com/listener for privacy information.

Episoder(2646)

Populært innen Business og økonomi

stopp-verden
dine-penger-pengeradet
lydartikler-fra-aftenposten
e24-podden
rss-borsmorgen-okonominyhetene
rss-penger-polser-og-politikk
pengepodden-2
finansredaksjonen
utbytte
livet-pa-veien-med-jan-erik-larssen
rss-sunn-okonomi
morgenkaffen-med-finansavisen
okonomiamatorene
tid-er-penger-en-podcast-med-peter-warren
lederpodden
pengesnakk
liberal-halvtime
rss-investering-gjort-enkelt
rss-andelige-tanker-med-camillo
rss-markedspuls-2